-+ 0.00%
-+ 0.00%
-+ 0.00%

MAZE THERAPEUTICS, INC. : CITIGROUP INITIATES COVERAGE WITH BUY RATING; PRICE TARGET $50

Reuters·09/23/2026 09:58:01